Impact of kinase activating and inactivating patient mutations on binary PKA interactions

Frontiers in Pharmacology

Volumn 6, Issue Aug, 2015, Pages

  Röck, Ruth ^a   Mayrhofer, Johanna E ^a   Bachmann, Verena ^a   Stefan, Eduard ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Acrodysostosis; CAMP dependent protein kinase A; Carney complex; GPCR; Molecular interactions; Patient mutations; Protein fragment complementation assay

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; LUCIFERASE; PROTEIN KINASE INHIBITOR;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE; GENE MUTATION; HUMAN; HUMAN CELL; PKAC GENE; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION; RIA GENE;

EID: 84940984098     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00170     Document Type: Article

References (52)

1. Assié, G. (2012). One single signaling pathway for so many different biological functions: lessons from the cyclic adenosine monophosphate/protein kinase A pathway-related diseases. J. Clin. Endocrinol. Metab. 97, 4355-4357. doi: 10.1210/jc.2012-3659
2. Bachmann, V. A., Riml, A., Huber, R. G., Baillie, G. S., Liedl, K. R., Valovka, T., et al. (2013). Reciprocal regulation of PKA and Rac signaling. Proc. Natl. Acad. Sci. U.S.A. 110, 8531-8536. doi: 10.1073/pnas.1215902110
3. Baillie, G. S., Sood, A., McPhee, I., Gall, I., Perry, S. J., Lefkowitz, R. J., et al. (2003). Beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc. Natl. Acad. Sci. U.S.A. 100, 940-945. doi: 10.1073/pnas.262787199
4. Bertherat, J., Horvath, A., Groussin, L., Grabar, S., Boikos, S., Cazabat, L., et al. (2009). Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J. Clin. Endocrinol. Metab. 94, 2085-2091. doi: 10.1210/jc.2008-2333
5. Beuschlein, F., Fassnacht, M., Assié, G., Calebiro, D., Stratakis, C. A., Osswald, A., et al. (2014). Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N. Engl. J. Med. 370, 1019-1028. doi: 10.1056/NEJMoa1310359
6. Calebiro, D., Hannawacker, A., Lyga, S., Bathon, K., Zabel, U., Ronchi, C., et al. (2014). PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunit. Nat. Commun. 5, 5680. doi: 10.1038/ncomms6680
7. Cao, Y., He, M., Gao, Z., Peng, Y., Li, Y., Li, L., et al. (2014). Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome. Science 344, 913-917. doi: 10.1126/science.1249480
8. Carney, J. A., Gordon, H., Carpenter, P. C., Shenoy, B. V., and Go, V. L. (1985). The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore). 64, 270-283. doi: 10.1097/00005792-198507000-00007
9. Cheung, J., Ginter, C., Cassidy, M., Franklin, M. C., Rudolph, M. J., Robine, N., et al. (2015). Structural insights into mis-regulation of protein kinase A in human tumors. Proc. Natl. Acad. Sci. U.S.A. 112, 1374-1379. doi: 10.1073/pnas.1424206112
10. Clapham, D. E. (2007). Calcium signaling. Cell 131, 1047-1058. doi: 10.1016/j.cell.2007.11.028
11. Daaka, Y., Luttrell, L. M., and Lefkowitz, R. J. (1997). Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390, 88-91. doi: 10.1038/36362
12. Dalton, G. D., and Dewey, W. L. (2006). Protein kinase inhibitor peptide (PKI): a family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function. Neuropeptides 40, 23-34. doi: 10.1016/j.npep.2005.10.002
13. Day, R. N., Walder, J. A., and Maurer, R. A. (1989). A protein kinase inhibitor gene reduces both basal and multihormone-stimulated prolactin gene transcription. J. Biol. Chem. 264, 431-436.
14. Dessauer, C. W. (2009). Adenylyl cyclase-A-kinase anchoring protein complexes: the next dimension in cAMP signaling. Mol. Pharmacol. 76, 935-941. doi: 10.1124/mol.109.059345
15. Di Dalmazi, G., Kisker, C., Calebiro, D., Mannelli, M., Canu, L., Arnaldi, G., et al. (2014). Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study. J. Clin. Endocrinol. Metab. 99, E2093-E2100. doi: 10.1210/jc.2014-2152
16. Espiard, S., Ragazzon, B., and Bertherat, J. (2014). Protein kinase a alterations in adrenocortical tumors. Horm. Metab. Res. 46, 869-875. doi: 10.1055/s-0034-1385908
17. Filteau, M., Diss, G., Torres-Quiroz, F., Dubé, A. K., Schraffl, A., Bachmann, V. A., et al. (2015). Systematic identification of signal integration by protein kinase A. Proc. Natl. Acad. Sci. U.S.A. 112, 4501-4506. doi: 10.1073/pnas.1409938112
18. Goh, G., Scholl, U. I., Healy, J. M., Choi, M., Prasad, M. L., Nelson-Williams, C., et al. (2014). Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat. Genet. 46, 613-617. doi: 10.1038/ng.2956
19. Groussin, L., Kirschner, L. S., Vincent-Dejean, C., Perlemoine, K., Jullian, E., Delemer, B., et al. (2002). Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am. J. Hum. Genet. 71, 1433-1442. doi: 10.1086/344579
20. Honeyman, J. N., Simon, E. P., Robine, N., Chiaroni-Clarke, R., Darcy, D. G., Lim, I. I., et al. (2014). Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma. Science 343, 1010-1014. doi: 10.1126/science.1249484
21. Horvath, A., Bertherat, J., Groussin, L., Guillaud-Bataille, M., Tsang, K., Cazabat, L., et al. (2010). Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update. Hum. Mutat. 31, 369-379. doi: 10.1002/humu.21178
22. Houslay, M. D. (2010). Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown. Trends Biochem. Sci. 35, 91-100. doi: 10.1016/j.tibs.2009.09.007
23. Kim, C., Cheng, C. Y., Saldanha, S. A., and Taylor, S. S. (2007). PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation. Cell 130, 1032-1043. doi: 10.1016/j.cell.2007.07.018
24. Lefkowitz, R. J. (2007). Seven transmembrane receptors: something old, something new. Acta Physiol. (Oxf). 190, 9-19. doi: 10.1111/j.1365-201X.2007.01693.x
25. Li, X., Wang, X., and Snyder, M. (2013). Systematic investigation of protein-small molecule interactions. IUBMB Life 65, 2-8. doi: 10.1002/iub.1111
26. Lignitto, L., Arcella, A., Sepe, M., Rinaldi, L., Delle Donne, R., Gallo, A., et al. (2013). Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth. Nat. Commun. 4, 1822. doi: 10.1038/ncomms2791
27. Lignitto, L., Carlucci, A., Sepe, M., Stefan, E., Cuomo, O., Nisticò, R., et al. (2011). Control of PKA stability and signalling by the RING ligase praja2. Nat. Cell Biol. 13, 412-422. doi: 10.1038/ncb2209
28. Linglart, A., Menguy, C., Couvineau, A., Auzan, C., Gunes, Y., Cancel, M., et al. (2011). Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance. N. Engl. J. Med. 364, 2218-2226. doi: 10.1056/NEJMoa1012717
29. Meoli, E., Bossis, I., Cazabat, L., Mavrakis, M., Horvath, A., Stergiopoulos, S., et al. (2008). Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors. Cancer Res. 68, 3133-3141. doi: 10.1158/0008-5472.CAN-08-0064
30. Neves, S. R., Ram, P. T., and Iyengar, R. (2002). G protein pathways. Science 296, 1636-1639. doi: 10.1126/science.1071550
31. O'Hayre, M., Degese, M. S., and Gutkind, J. S. (2014). Novel insights into G protein and G protein-coupled receptor signaling in cancer. Curr. Opin. Cell Biol. 27, 126-135. doi: 10.1016/j.ceb.2014.01.005
32. Pierce, K. L., Premont, R. T., and Lefkowitz, R. J. (2002). Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3, 639-650. doi: 10.1038/nrm908
33. Röck, R., Bachmann, V., Bhang, H. E., Malleshaiah, M., Raffeiner, P., Mayrhofer, J. E., et al. (2015). In-vivo detection of binary PKA network interactions upon activation of endogenous GPCRs. Sci. Rep. 5:11133. doi: 10.1038/srep11133
34. Salpea, P., and Stratakis, C. A. (2014). Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics. Mol. Cell. Endocrinol. 386, 85-91. doi: 10.1016/j.mce.2013.08.022
35. Sato, Y., Maekawa, S., Ishii, R., Sanada, M., Morikawa, T., Shiraishi, Y., et al. (2014). Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome. Science 344, 917-920. doi: 10.1126/science.1252328
36. Scott, J. D., and Pawson, T. (2009). Cell signaling in space and time: where proteins come together and when they're apart. Science 326, 1220-1224. doi: 10.1126/science.1175668
37. Scott, J. D., Dessauer, C. W., and Taskén, K. (2013). Creating order from chaos: cellular regulation by kinase anchoring. Annu. Rev. Pharmacol. Toxicol. 53, 187-210. doi: 10.1146/annurev-pharmtox-011112-140204
38. Scott, J. D., Fischer, E. H., Demaille, J. G., and Krebs, E. G. (1985). Identification of an inhibitory region of the heat-stable protein inhibitor of the cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. U.S.A. 82, 4379-4383. doi: 10.1073/pnas.82.13.4379
39. Silve, C., Clauser, E., and Linglart, A. (2012). Acrodysostosis. Horm. Metab. Res. 44, 749-758. doi: 10.1055/s-0032-1316330
40. Skroblin, P., Grossmann, S., Schäfer, G., Rosenthal, W., and Klussmann, E. (2010). Mechanisms of protein kinase A anchoring. Int. Rev. Cell Mol. Biol. 283, 235-330. doi: 10.1016/S1937-6448(10)83005-9
41. Søberg, K., Larsen, A. C., Diskar, M., Backe, P. H., Bjørås, M., Jahnsen, T., et al. (2012). Identification and characterization of novel mutations in the human gene encoding the catalytic subunit Calpha of protein kinase A (PKA). PLoS ONE 7:e34838. doi: 10.1371/journal.pone.0034838
42. Stefan, E., Aquin, S., Berger, N., Landry, C. R., Nyfeler, B., Bouvier, M., et al. (2007). Quantification of dynamic protein complexes using Renilla luciferase fragment complementation applied to protein kinase A activities in vivo. Proc. Natl. Acad. Sci. U.S.A. 104, 16916-16921. doi: 10.1073/pnas.0704257104
43. Stefan, E., Malleshaiah, M. K., Breton, B., Ear, P. H., Bachmann, V., Beyermann, M., et al. (2011). PKA regulatory subunits mediate synergy among conserved G-protein-coupled receptor cascades. Nat. Commun. 2, 598. doi: 10.1038/ncomms1605
44. Stratakis, C. A. (2013). cAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse. Mol. Cell. Endocrinol. 371, 208-220. doi: 10.1016/j.mce.2013.01.015
45. Taylor, S. S., Ilouz, R., Zhang, P., and Kornev, A. P. (2012). Assembly of allosteric macromolecular switches: lessons from PKA. Nat. Rev. Mol. Cell Biol. 13, 646-658. doi: 10.1038/nrm3432
46. Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., et al. (2006). Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 12, 939-944. doi: 10.1038/nm1447
47. Veugelers, M., Wilkes, D., Burton, K., McDermott, D. A., Song, Y., Goldstein, M. M., et al. (2004). Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc. Natl. Acad. Sci. U.S.A. 101, 14222-14227. doi: 10.1073/pnas.0405535101
48. Walsh, D. A., Ashby, C. D., Gonzalez, C., Calkins, D., Fischer, E. H., and Krebs, E. G. (1971). Purification and characterization of a protein inhibitor of adenosine 3',5'-monophosphate-dependent protein kinases. J. Biol. Chem. 246, 1977-1985.
49. Wong, W., and Scott, J. D. (2004). AKAP signalling complexes: focal points in space and time. Nat. Rev. Mol. Cell Biol. 5, 959-970. doi: 10.1038/nrm1527
50. Zhang, J., Hupfeld, C. J., Taylor, S. S., Olefsky, J. M., and Tsien, R. Y. (2005). Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes. Nature 437, 569-573. doi: 10.1038/nature04140
51. Zhang, P., Smith-Nguyen, E. V., Keshwani, M. M., Deal, M. S., Kornev, A. P., and Taylor, S. S. (2012). Structure and allostery of the PKA RIIbeta tetrameric holoenzyme. Science 335, 712-716. doi: 10.1126/science.1213979
52. Zilbermint, M., and Stratakis, C. A. (2015). Protein kinase A defects and cortisol-producing adrenal tumors. Curr. Opin. Endocrinol. Diabetes Obes. 22, 157-162. doi: 10.1097/MED.0000000000000149